GlassScriptPhysician profile
Daniel M Goldfaden
NPI 1619038080
$570.62
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $43.78.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $240.23 | 2019-2020 | |
| Livanova USA, INC. | $121.69 | 2019 | |
| Atricure, INC. | $89.37 | 2019 | |
| Abiomed | $25.41 | 2019 | |
| Getinge USA Sales, LLC | $20.24 | 2019 | |
| Abbott Laboratories | $17.33 | 2019 | |
| Varian Medical Systems, INC. | $15.54 | 2020 | |
| Davol INC. | $15.46 | 2019 | |
| Medtronic Vascular, INC. | $14.50 | 2019 | |
| Terumo Cardiovascular Systems Corporation | $10.85 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Goldfaden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.